In a filing, ANI Pharmaceuticals Inc revealed its Director Leonard Matthew J unloaded Company’s shares for reported $0.23 million on Aug 25 ’25. In the deal valued at $90.62 per share,2,528 shares were sold. As a result of this transaction, Leonard Matthew J now holds 6,864 shares worth roughly $0.64 million.
Then, MATTHEW LEONARD bought 2,528 shares, generating $229,076 in total proceeds.
Before that, Davis Krista sold 1,763 shares. ANI Pharmaceuticals Inc shares valued at $160,609 were divested by the SVP, CHIEF HR OFFICER at a price of $91.10 per share. As a result of the transaction, Davis Krista now holds 62,896 shares, worth roughly $5.88 million.
H.C. Wainwright initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on July 10, 2025; the price target was $84. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. JP Morgan began covering ANIP with “an Overweight” recommendation on March 12, 2025. Leerink Partners started covering the stock on December 11, 2024. It rated ANIP as “an Outperform”.
Price Performance Review of ANIP
On Friday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock jump 1.05% to $93.5. Over the last five days, the stock has gained 2.74%. ANI Pharmaceuticals Inc shares have risen nearly 47.83% since the year began. Nevertheless, the stocks have risen 69.14% over the past one year. While a 52-week high of $92.65 was reached on 08/29/25, a 52-week low of $52.50 was recorded on 01/13/25.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 92.41, which if violated will result in even more drops to 91.32. On the upside, there is a resistance level at 94.15. A further resistance level may holdings at 94.81.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2025-08-15, growing by 75162.0 shares to a total of 2.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 2.13 million shares. There was a rise of 3.41%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 11, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $68 price target.